Encompass Health (EHC) Shares Soar 2.26% to Record High on Analyst Optimism

Encompass Health (EHC) shares surged to a record high today, with an intraday gain of 2.26%.

Several analysts have recently adjusted their price targets for Encompass Health, reflecting a positive outlook on the company's financial performance. Truist increased its price target from $116 to $135, while Raymond James raised its target from $120 to $130, maintaining a Strong Buy rating. UBS also adjusted its price target to $130, with an average rating of buy and a mean price target of $129.18. Additionally, Mizuho Securities raised its price target to $130 from $110, indicating a favorable financial outlook.

These adjustments suggest that analysts are optimistic about Encompass Health's future prospects, which has contributed to the recent surge in the company's stock price. The positive sentiment from analysts, coupled with strong stock performance, has driven investor confidence in Encompass Health, leading to the record high achieved today.